On, February, 22, 2023, Moderna Inc. said that US regulators have given its experimental personalised mRNA skin cancer vaccine and Merck & Co.’s drug Keytruda the designation of breakthrough therapies as an additional treatment for high-risk patients. After the market closed Moderna shares rose 2.5% to $164. Based on data from a mid-stage drug study […]
Continue Reading
On Monday, February 13, 2023, Natco Pharma announced that it had submitted a new application to the US health regulator for marketing authorization of the generic version of Olaparib tablets, which are used to treat some types of ovarian, breast, pancreatic, and prostate cancer. The generic version of AstraZeneca’s Olaparib tablets in strengths of 100mg […]
Continue Reading
According to a latest study, the overall cancer death rates in the United States continue to decrease among women, men, teens, children, and young adults. The annual report from the American Cancer Society to the Nation on the Status of Cancer showed a decrease in every major racial and ethnic group from 2015 to 2019. […]
Continue Reading
The US Food and Drug Administration (FDA), announced that the pharmaceutical company Aurobindo Pharma is recalling a blood pressure medication because of a potential cancer risk. The company is recalling two lots of quinapril and hydrochlorothiazide tablets because of the levels of nitrosamine. The tablets are most commonly prescribed for the treatment of hypertension to […]
Continue Reading